Global Cord Blood Corporation

2.68-0.0100-0.37%Vol 88.60K1Y Perf -48.96%
May 18th, 2022 16:00 DELAYED
BID2.48 ASK3.10
Open2.69 Previous Close2.69
Pre-Market- After-Market-
 - -  - -%
Target Price
6.50 
Analyst Rating
— 0.00
Potential %
142.54 
Finscreener Ranking
★★★★★ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     73.30
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★★     76.80
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★+ —    -
Price Range Ratio 52W %
13.78 
Earnings Rating
Buy
Market Cap325.76M 
Earnings Date
27th Jun 2022
Alpha-0.01 Standard Deviation0.10
Beta0.39 

Today's Price Range

2.602.70

52W Range

2.106.31

5 Year PE Ratio Range

4.6064.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
14.96%
1 Month
-27.49%
3 Months
-39.00%
6 Months
-37.00%
1 Year
-48.96%
3 Years
-58.42%
5 Years
-64.93%
10 Years
-3.24%

TickerPriceChg.Chg.%
CO2.68-0.0100-0.37
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
10.50
10.70
0.00
0.00
-
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
85.00
49.30
49.30
43.70
42.57
RevenueValueIndustryS&P 500US Markets
148.85M
1.22
1.94
7.32
Earnings HistoryEstimateReportedSurprise %
Q03 2022-0.17-
Q02 2022-0.16-
Q01 2022-0.17-
Q02 2021-0.16-
Q01 2021-0.15-
Q04 2020-0.11-
Q03 2020-0.17-
Q02 2020-0.14-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date27th Jun 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume88.60K
Shares Outstanding121.55K
Shares Float34.73M
Trades Count782
Dollar Volume236.49K
Avg. Volume163.78K
Avg. Weekly Volume106.89K
Avg. Monthly Volume234.70K
Avg. Quarterly Volume149.76K

Global Cord Blood Corporation (NYSE: CO) stock closed at 2.69 per share at the end of the most recent trading day (a 1.89% change compared to the prior day closing price) with a volume of 91.41K shares and market capitalization of 325.76M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 1260 people. Global Cord Blood Corporation CEO is Ting Zheng.

The one-year performance of Global Cord Blood Corporation stock is -48.96%, while year-to-date (YTD) performance is -35.8%. CO stock has a five-year performance of -64.93%. Its 52-week range is between 2.1 and 6.31, which gives CO stock a 52-week price range ratio of 13.78%

Global Cord Blood Corporation currently has a PE ratio of 4.10, a price-to-book (PB) ratio of 0.47, a price-to-sale (PS) ratio of 2.16, a price to cashflow ratio of 3.30, a PEG ratio of 2.32, a ROA of 6.81%, a ROC of 11.01% and a ROE of 12.14%. The company’s profit margin is 42.57%, its EBITDA margin is 49.30%, and its revenue ttm is $148.84 Million , which makes it $1.22 revenue per share.

Of the last four earnings reports from Global Cord Blood Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Global Cord Blood Corporation’s next earnings report date is 27th Jun 2022.

The consensus rating of Wall Street analysts for Global Cord Blood Corporation is (0), with a target price of $6.5, which is +142.54% compared to the current price. The earnings rating for Global Cord Blood Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Global Cord Blood Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of 20.00%.

Global Cord Blood Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 12.15, ATR14 : 0.24, CCI20 : -29.42, Chaikin Money Flow : 0.07, MACD : -0.32, Money Flow Index : 31.84, ROC : -21.57, RSI : 41.25, STOCH (14,3) : 41.55, STOCH RSI : 0.95, UO : 43.03, Williams %R : -58.45), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Global Cord Blood Corporation in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Hold
3.00

Global Cord Blood Corporation

Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.

CEO: Ting Zheng

Telephone: +852 36058180

Address: 1 Garden Road, Hong Kong , , HK

Number of employees: 1 260

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

58%42%

Bearish Bullish

50%50%

News

Stocktwits